tiprankstipranks
Trending News
More News >
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Financial Statements

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Financial Overview

BrightPath Biotherapeutics Co.Ltd.'s market cap is currently ¥3.74B. The company's EPS TTM is ¥-3.82; its P/E ratio is ―; BrightPath Biotherapeutics Co.Ltd. is scheduled to report earnings on May 9, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 1.13M¥ 72.00K¥ 5.28M¥ 15.41M¥ 2.50M
Gross Profit¥ 1.10M¥ -341.00K¥ 3.38M¥ 12.09M¥ 1.36M
Operating Income¥ -1.16B¥ -1.16B¥ -1.47B¥ -1.48B¥ -1.73B
EBITDA¥ -1.15B¥ -1.17B¥ -1.47B¥ -1.45B¥ -1.65B
Net Income¥ -1.15B¥ -1.17B¥ -1.49B¥ -1.48B¥ -1.72B
Balance Sheet
Cash & Short-Term Investments¥ 810.47M¥ 1.06B¥ 1.53B¥ 2.31B¥ 3.27B
Total Assets¥ 1.12B¥ 1.23B¥ 1.70B¥ 2.77B¥ 3.75B
Total Debt¥ 25.00M¥ 112.50M¥ 0.00¥ 87.50M¥ 0.00
Net Debt¥ -785.47M¥ -944.86M¥ -1.53B¥ -2.22B¥ -3.27B
Total Liabilities¥ 195.62M¥ 251.27M¥ 133.91M¥ 239.73M¥ 211.79M
Stockholders' Equity¥ 924.99M¥ 978.99M¥ 1.57B¥ 2.53B¥ 3.54B
Cash Flow
Free Cash Flow¥ -1.25B¥ -1.16B¥ -1.21B¥ -1.53B¥ -1.81B
Operating Cash Flow¥ -1.25B¥ -1.16B¥ -1.20B¥ -1.51B¥ -1.77B
Investing Cash Flow¥ -1.37M¥ -7.65M¥ -1.76M¥ -17.57M¥ -36.21M
Financing Cash Flow¥ 1.00B¥ 690.96M¥ 432.10M¥ 569.23M¥ 2.05B
Currency in JPY

BrightPath Biotherapeutics Co.Ltd. Earnings and Revenue History

BrightPath Biotherapeutics Co.Ltd. Debt to Assets

BrightPath Biotherapeutics Co.Ltd. Cash Flow

BrightPath Biotherapeutics Co.Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis